OrbiMed has announced it has raised more than $4.3 billion in commitments for its latest private investment funds.

These new funds include OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.

OrbiMed, headquartered in New York, is a life sciences investment firm with more than $17 billion in assets under management.